ARTICLE DOWNLOAD

Antibodies to Crohn’s disease peptide 353 as a diagnostic marker for pediatric Crohn’s disease: a prospective multicenter study in Japan

10$
ARTICLE DOWNLOAD

Antibodies to Crohn’s disease peptide 353 as a diagnostic marker for pediatric Crohn’s disease: a prospective multicenter study in Japan

10$

Tatsuki Mizuochi, Katsuhiro Arai, Takahiro Kudo, Ryusuke Nambu, Hitoshi Tajiri, Tomoki Aomatsu, Naoki Abe, Toshihiko Kakiuchi, Kunio Hashimoto, Tsuyoshi Sogo, Michiko Takahashi, Yuri Etani, Yugo Takaki, Ken-ichiro Konishi, Jun Ishihara, Hitoshi Obara, Tatsuyuki Kakuma, Shunsuke Kurei, Yushiro Yamashita & Keiichi Mitsuyama 

Abstract

Background

Various serologic markers such as anti-glycoprotein 2 antibodies and anti-Saccharomyces cerevisiae antibodies have been reported to be diagnostically useful in Crohn’s disease. Mitsuyama et al. reported that antibodies to Crohn’s disease peptide 353, a newly proposed serologic marker, were more useful in Japanese adults than anti-Saccharomyces. We addressed the same issue in Japanese children and adolescents.

Methods

Prospectively enrolled subjects under 17 years old assessed and treated at 12 pediatric centers in Japan included groups with Crohn’s disease, ulcerative colitis, other intestinal diseases, or good health. The 3 serum markers were analyzed by enzyme-linked immunosorbent assays.

Results

Enrolled subjects, numbering 367, included 120 with Crohn’s disease, 148 with ulcerative colitis, 56 with other intestinal diseases, and 43 healthy subjects. In Crohn’s disease, anti-Crohn’s disease peptide 353, anti-glycoprotein 2, and anti-Saccharomyces concentrations (median, 2.25, 3.0, and 8.9 U/mL) were significantly greater than in ulcerative colitis (1.1, 1.9, and 3.4; all P < 0.001), other intestinal diseases (1.1, 1.85, and 2.95; all P < 0.001), and healthy controls (1.1, 1.7, and 2.8; all P < 0.001), respectively. At 95% specificity, sensitivity of anti-Crohn’s disease peptide (45.0%) was significantly higher than for anti-glycoprotein 2 (30.8%; P < 0.05) or anti-Saccharomyces (26.7%; P < 0.01).

Conclusions

Anti-Crohn’s disease peptide 353 proved more useful for diagnosis of Crohn’s disease in Japanese children than the other 2 markers. To our knowledge, this is the first pediatric report to that effect.

Only units of this product remain
Year 2020
Language English
Format PDF
DOI 10.1007/s00535-019-01661-y